UChicago Medicine Faculty Physicians
Arlene Chapman, MD
Arlene Chapman, MD
UChicago Medicine Faculty Physicians
Professor of Medicine
Specialties
- Nephrology (Kidney Disease)
Locations
- Chicago - Hyde Park
- Chicago - River East
Schedule an Appointment
Schedule an Appointment- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
A renowned nephrologist, Arlene Chapman, MD, is dedicated to improving the lives of patients with renal disease. Dr. Chapman's career has focused on hereditary renal diseases, specifically autosomal dominant polycystic kidney disease, as well as other rare conditions including autosomal recessive kidney diseases, the CAKUT disorders, ciliopathies, tuberous sclerosis complex and von Hippel Lindau disease. Dr. Chapman also sees patients with chronic kidney disease of all causes, and those who are pregnant with underlying renal disease.
Dr. Chapman's research focuses on mechanisms of cyst formation in autosomal dominant polycystic kidney disease. She has been integrally involved in the development of novel imaging biomarkers for this disease. Dr. Chapman also studies personalized or precision medicine and the role that genetic background plays in predicting antihypertensive responses to blood pressure medications used to treat hypertension. Dr. Chapman's early investigations centered on the renal and systemic changes to blood circulation that occur during preeclampsia. She has received continuous funding for her work from the National Institutes of Health (NIH) over the past 18 years.
Dr. Chapman's academic contributions include membership on several NIH committees as well as the Scientific Advisory Council for the Polycystic Kidney Disease Research Foundation and the Council for the American Kidney Societies. Dr. Chapman is the current director of the Clinical Resource Center for the Institute of Translational Medicine in the Biological Sciences Division at the University of Chicago. She has published nearly 170 peer-reviewed publications and book chapters, and previously served on the editorial boards for American Journal of Kidney Diseases, Kidney International and the Journal of the American Society of Nephrology.
In addition, Dr. Chapman is a dedicated mentor and educator for medical students, interns and residents. She is actively involved in teaching fellows about various topics in nephrology and guides them in their research.
Dr. Chapman's research focuses on mechanisms of cyst formation in autosomal dominant polycystic kidney disease. She has been integrally involved in the development of novel imaging biomarkers for this disease. Dr. Chapman also studies personalized or precision medicine and the role that genetic background plays in predicting antihypertensive responses to blood pressure medications used to treat hypertension. Dr. Chapman's early investigations centered on the renal and systemic changes to blood circulation that occur during preeclampsia. She has received continuous funding for her work from the National Institutes of Health (NIH) over the past 18 years.
Dr. Chapman's academic contributions include membership on several NIH committees as well as the Scientific Advisory Council for the Polycystic Kidney Disease Research Foundation and the Council for the American Kidney Societies. Dr. Chapman is the current director of the Clinical Resource Center for the Institute of Translational Medicine in the Biological Sciences Division at the University of Chicago. She has published nearly 170 peer-reviewed publications and book chapters, and previously served on the editorial boards for American Journal of Kidney Diseases, Kidney International and the Journal of the American Society of Nephrology.
In addition, Dr. Chapman is a dedicated mentor and educator for medical students, interns and residents. She is actively involved in teaching fellows about various topics in nephrology and guides them in their research.
Specialties
Areas of Expertise
- Pregnancy & Kidney Disease
- Hereditary Kidney Diseases
- Essential Hypertension (Primary Hypertension)
UChicago Medicine Duchossois Center for Advanced Medicine - Hyde Park5758 S. Maryland Ave., Chicago IL 606371-888-824-0200
Board Certifications
- Internal Medicine
- Nephrology
Practicing Since
- 1986
Languages Spoken
- English
Medical Education
- McMaster University School of Medicine
Memberships & Medical Societies
- American Heart Association
- American Society of Nephrology
- International Society of Nephrology
- National Kidney Foundation
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If your insurance company is not listed here, or if you have any other questions, please contact Managed.Care@uchospitals.edu.
*Click Here to visit our insurance page and learn more.
UChicago Medicine is committed to fostering a corporate culture of ethical behavior and integrity in all matters related to compliance with the laws and regulations that govern the delivery of healthcare. This aspiration is central to supporting patient care, research, and teaching at UChicago Medicine.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.